ArticleOncotarget2015

Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype.

Maria Rita Milone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.